Therapeutics Stocks

Showing 741 articles
Business

Foraco International's Surging Profitability Catches Investor Attention

The drilling services firm Foraco International (TSE:FAR) is demonstrating a powerful trend of improving capital efficiency, with its Return on Capital Employed (ROCE) jumping 53% over five years. This signals a company that's generating significantly more profit from each dollar invested, a key marker often sought by long-term investors.

Business

Figma's AI Pivot Tests Investor Faith Amid Software Sector Shakeout

As the software sector faces a broad sell-off, Figma's valuation is being scrutinized through a dual lens: fears of AI disruption to traditional design work and optimism over its own AI-integrated platform. With short interest easing, the market is weighing the company's long-term positioning at the convergence of collaboration and automation.